Cartesian Therapeutics(DE:1S70)
€5.25-0.40 (-7.08%)
DE:1S70
Cartesian Therapeutics earnings date
€5.25
At close:-0.40 (-7.08%)
Cartesian Therapeutics (1S70) Q2 2023 Earnings Report
1 Followers
DE:1S70 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.06
- Consensus EPS
- -EUR 0.11
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- EUR 0.05
DE:1S70 Q2 2023 Revenue Results
- Actual Revenue
- EUR 4.70M
- Expected Revenue
- EUR 5.01M
- Beat/Miss
- Missed by -EUR 314.27K
- YoY Revenue Growth
- -86.63%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/17/2023
- Time
- Before Open
- Conference Call
- Thursday, August 17, 2023
DE:1S70 Upcoming Earnings
Cartesian Therapeutics's next earnings date is estimated for March 17, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:1S70 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1S70 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 17, 2027 | 2026 (Q4) | -0.81- | -3.1 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.90-0.34 | -1.24 | 72.46% (+0.90) | |
| Aug 06, 2026 | 2026 (Q2) | -0.790.41 | 0.45 | -8.00% (-0.04) | |
| May 07, 2026 | 2026 (Q1) | -0.78-1.31 | -0.61 | -114.71% (-0.70) | |
| Mar 09, 2026 | 2025 (Q4) | -0.76-3.10 | -0.53 | -485.45% (-2.57) | |
| Nov 06, 2025 | 2025 (Q3) | -0.76-1.24 | -1.01 | -22.12% (-0.22) | |
| Aug 07, 2025 | 2025 (Q2) | -0.720.45 | 0.48 | -7.41% (-0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.63-0.61 | -9.4 | 93.52% (+8.79) | |
| Mar 13, 2025 | 2024 (Q4) | -0.74-0.53 | -1.94 | 72.76% (+1.41) | |
| Nov 07, 2024 | 2024 (Q3) | -0.72-1.01 | -1.21 | 16.30% (+0.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

